Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1984 1
1985 1
1986 2
1987 3
1988 2
1989 3
1990 5
1991 5
1994 1
1995 4
1996 3
1997 1
1998 1
2000 1
2001 2
2002 3
2003 4
2004 5
2005 11
2006 8
2007 11
2008 8
2009 12
2010 11
2011 7
2012 12
2013 13
2014 8
2015 13
2016 11
2017 17
2018 12
2019 12
2020 12
2021 9
2022 9
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Clinical Trial.
The pellicle and erosion.
Hannig M, Hannig C. Hannig M, et al. Among authors: hannig c. Monogr Oral Sci. 2014;25:206-14. doi: 10.1159/000360376. Epub 2014 Jun 26. Monogr Oral Sci. 2014. PMID: 24993268 Review.
Preventive Applications of Polyphenols in Dentistry-A Review.
Flemming J, Meyer-Probst CT, Speer K, Kölling-Speer I, Hannig C, Hannig M. Flemming J, et al. Among authors: hannig c. Int J Mol Sci. 2021 May 5;22(9):4892. doi: 10.3390/ijms22094892. Int J Mol Sci. 2021. PMID: 34063086 Free PMC article. Review.
Lipids in preventive dentistry.
Kensche A, Reich M, Kümmerer K, Hannig M, Hannig C. Kensche A, et al. Among authors: hannig c. Clin Oral Investig. 2013 Apr;17(3):669-85. doi: 10.1007/s00784-012-0835-9. Epub 2012 Sep 28. Clin Oral Investig. 2013. PMID: 23053698 Review.
[Esophageal motility disorders].
Hannig C, Wuttge-Hannig A, Rummeny E. Hannig C, et al. Radiologe. 2007 Feb;47(2):123-36. doi: 10.1007/s00117-007-1472-1. Radiologe. 2007. PMID: 17256114 Review. German.
Nanotechnology and its role in caries therapy.
Hannig M, Hannig C. Hannig M, et al. Among authors: hannig c. Adv Dent Res. 2012 Sep;24(2):53-7. doi: 10.1177/0022034512450446. Adv Dent Res. 2012. PMID: 22899680 Review.
227 results